Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences

Cisplatin (CDDP) has been widely used as a chemotherapeutic agent for solid tumors. The most common side effect of CDDP is nephrotoxicity, and many efforts have been made in the laboratory and the clinic to employ candidate adjuvants to CDDP to minimize this adverse influence. Many synthetic and her...

Descripción completa

Detalles Bibliográficos
Autores principales: Nematbakhsh, Mehdi, Pezeshki, Zahra, Jazi, Fatemeh Eshraghi, Mazaheri, Bahar, Moeini, Maryam, Safari, Tahereh, Azarkish, Fariba, Moslemi, Fatemeh, Maleki, Maryam, Rezaei, Alireza, Saberi, Shadan, Dehghani, Aghdas, Malek, Maryam, Mansouri, Azam, Ghasemi, Marzieh, Zeinali, Farzaneh, Zamani, Zohreh, Navidi, Mitra, Jilanchi, Sima, Shirdavani, Soheyla, Ashrafi, Farzaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454720/
https://www.ncbi.nlm.nih.gov/pubmed/28345324
http://dx.doi.org/10.22034/APJCP.2017.18.2.295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454720/
https://www.ncbi.nlm.nih.gov/pubmed/28345324
http://dx.doi.org/10.22034/APJCP.2017.18.2.295

Ejemplares similares